Antibiotic consumption and antibiotic stewardship in Swedish hospitals

  • Håkan Hanberger Division of Infectious Diseases, Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, Linköping, Sweden; and County Council of Östergötland, Linköping, Sweden
  • Gunilla Skoog The Public Health Agency of Sweden, Solna, Sweden
  • Anders Ternhag The Public Health Agency of Sweden, Solna, Sweden; and Department of Medicine, Division of Infectious Diseases, Karolinska Institute, Stockholm, Sweden
  • Christian G. Giske The Department of Clinical Microbiology, Karolinska Institute MTC, Karolinska University Hospital, Stockholm, Sweden
Keywords: Antibiotic consumption, antibiotic resistance, antibiotic treatment guidelines

Abstract

Background. The aim of this paper was to describe and analyze the effect of antibiotic policy changes on antibiotic consumption in Swedish hospitals and to review antibiotic stewardship in Swedish hospitals.

Results. The main findings were: 1) Antibiotic consumption has significantly increased in Swedish hospitals over the last decade. The consumption of cephalosporins has decreased, whereas that of most other drugs including piperacillin-tazobactam, carbapenems, and penicillinase-sensitive and -resistant penicillins has increased and replaced cephalosporins. 2) Invasive infections caused by ESBL-producing Escherichia coli and Klebsiella pneumoniae have increased, but the proportion of pathogens resistant to third-generation cephalosporins causing invasive infections is still very low in a European and international perspective. Furthermore, the following gaps in knowledge were identified: 1) lack of national, regional, and local data on the incidence of antibiotic resistance among bacteria causing hospital-acquired infections e.g. bloodstream infections and hospital-acquired pneumonia—data on which standard treatment guidelines should be based; 2) lack of data on the incidence of Clostridium difficile infections and the effect of change of antibiotic policies on the incidence of C. difficile infections and infections caused by antibiotic-resistant pathogens; and 3) lack of prospective surveillance programs regarding appropriate antibiotic treatment, including selection of optimal antimicrobial drug regimens, dosage, duration of therapy, and adverse ecological effects such as increases in C. difficile infections and emergence of antibiotic-resistant pathogens.

Conclusions. Evidence-based actions to improve antibiotic use and to slow down the problem of antibiotic resistance need to be strengthened. The effect of such actions should be analyzed, and standard treatment guidelines should be continuously updated at national, regional, and local levels.

Downloads

Download data is not yet available.
Published
2014-04-11
How to Cite
Hanberger H., Skoog G., Ternhag A., & Giske C. G. (2014). Antibiotic consumption and antibiotic stewardship in Swedish hospitals. Upsala Journal of Medical Sciences, 119(2), 154–161. https://doi.org/10.3109/03009734.2014.909911